A taper plan used to be standard when antidepressants launched. Dr. Rabin explains what changed, and why almost nobody is trained to guide the exit today.
Most psychedelic medicines don't combine safely with antidepressants. Dr. Rabin explains the risk before it lands a client in the ER, and what to do instead.
Why antidepressant tapering has no one-size-fits-all protocol, how to tell withdrawal from relapse, and what practitioners need before psychedelic approval.
How SSRIs and psychedelics act differently on the brain, what the research supports, and why the distinction matters for practitioners seeing clients on SSRIs.
Shifting people’s perspectives so that they can see new possibilities that allow them to be kinder to themselves, others, and the planet is the driving force for me.